(Q45109507)

9 December 2017

title

Experience with a novel vaginal progesterone preparation in a donor oocyte program (English)

1 reference

9 December 2017

Gibbons WE

1

1 reference

9 December 2017

Toner JP

series ordinal

2

1 reference

9 December 2017

Hamacher P

series ordinal

3

1 reference

9 December 2017

Kolm P

series ordinal

4

1 reference

9 December 2017

language of work or name

English

0 references

publication date

1 January 1998

1 reference

9 December 2017

published in

Fertility and Sterility

1 reference

9 December 2017

volume

69

1 reference

9 December 2017

issue

1

1 reference

9 December 2017

page(s)

96-101

1 reference

The establishment and maintenance of pregnancy using in vitro fertilization and embryo donation in a patient with primary ovarian failure

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900457-3

Assisted reproductive technology in the United States and Canada: 1994 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900457-3

Sedative and hypnotic effects of oral administration of micronized progesterone may be mediated through its metabolites.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900457-3

Effects of natural progesterone on the morphology of the endometrium in patients with primary ovarian failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900457-3

Transfer of cryopreserved-thawed embryos: the natural cycle versus controlled preparation of the endometrium with gonadotropin-releasing hormone agonist and exogenous estradiol and progesterone (GEEP)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900457-3

Controlled preparation of the endometrium with exogenous estradiol and progesterone in women having functioning ovaries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900457-3

A prospective randomized comparison of intramuscular or intravaginal natural progesterone as a luteal phase and early pregnancy supplement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900457-3

Serial transvaginal ultrasound scans and beta-human chorionic gonadotropin levels in early singleton and multiple pregnancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900457-3

Transvaginal administration of progesterone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900457-3

Luteal support after in-vitro fertilization: Crinone 8%, a sustained release vaginal progesterone gel, versus Utrogestan, an oral micronized progesterone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900457-3

Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900457-3

10.1016/S0015-0282(97)00457-3

7 January 2021

Identifiers

DOI

1 reference

9 December 2017

1 reference